HOME Top Market Reports Breast Imaging Market by Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, Optical Imaging)) - Forecast to 2021

Breast Imaging Market by Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, Optical Imaging)) - Forecast to 2021

By: marketsandmarkets.com
Publishing Date: May 2016
Report Code: MD 2554

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


This report studies the breast imaging market over the forecast period of 2016 to 2021. The market is expected to reach USD 4.14 Billion by 2021, at a CAGR of 8.5% from 2016 to 2021. Growing incidence of breast cancer globally, rising government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues are some of the key factors driving the growth of this market. Also, increasing demand for breast imaging in emerging Asian countries and technological advancements in breast cancer detection are expected to offer growth opportunities for players operating in this market. However, factors such as high installation cost of breast imaging systems, side effects of radiation exposure, and errors in breast cancer screening and diagnosis are expected to restrain the growth of this market in the coming years.

Emerging countries, including China and India, are expected to offer significant growth opportunities to market players in the coming years. The growth in these markets will majorly be driven by rising incidence of breast cancer and significant investments by governments and leading players in emerging countries. Also, factors such as presence of less stringent regulatory guidelines, rising patient population, increasing healthcare expenditure, and improving healthcare infrastructure are expected to further drive the growth in these markets. In order to leverage the high growth opportunities in these markets, leading market players are expanding their presence in emerging countries.

As of 2015, Hologic, Inc. (U.S.) held the leadership position in the global breast imaging market. Over the past three years, the company has adopted product launches, upgrades, and approvals; and partnerships, agreements, and collaborations as its key business strategies to ensure its dominance in this market. GE Healthcare (U.K.), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), Fujifilm Holdings Corporation (Japan), Gamma Medica, Inc. (U.S.), Toshiba Corporation (Japan), Sonocine, Inc. (U.S.), Aurora Imaging Technology, Inc. (U.S.), and Dilon Technologies, Inc. (U.S.) are some of the other key players in this market.

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the breast imaging market into the following segments:

Global Breast Imaging Market, by Type

  • Ionizing Breast Imaging Technologies
    • Analog Mammography
    • Full-field Digital Mammography (FFDM)
    • 3D Breast Tomosynthesis
    • Positron Emission Tomography/Computed Tomography (PET/CT)
    • Molecular Breast Imaging/Breast-specific Gamma Imaging (MBI/BSGI)
    • Cone-beam Computed Tomography (CBCT)
    • Positron Emission Mammography (PEM)
    • Electric Impedance Tomography
  • Non-ionizing Breast Imaging Technologies
    • Breast MRI
    • Breast Ultrasound
    • Optical Imaging
    • Whole-breast Ultrasound
    • Breast Thermography

Global Breast Imaging Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe (RoE)
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Rest of the World

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
                    2.1.2.3 Key Industry Insights
    2.2 Market Size Estimation
                    2.2.1.1 Bottom-Up Approach
                    2.2.1.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions

3 Executive Summary (Page No. - 28)
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 33)
    4.1 Breast Imaging Market Overview
    4.2 Breast Imaging Market Share, By Type, 2016 vs. 2021
    4.3 Geographic Analysis: Ionizing Technologies Market, By Type
    4.4 Geographic Analysis: Non-Ionizing Technologies Market, By Type (2016)

5 Market Overview (Page No. - 36)
    5.1 Introduction
           5.1.1 Market Segmentation
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Growing Prevalence of Breast Cancer
                    5.2.1.2 Government Investments and Funding for Breast Cancer Treatment and Related Research
                    5.2.1.3 Increasing Awareness About Early Detection of Breast Cancer
                    5.2.1.4 Rapidly Increasing Aging Population
                    5.2.1.5 Technological Advancements in Breast Imaging Modalities
                    5.2.1.6 Launch of Advanced Systems Capable of Detecting Cancer in Women With Dense Breast Tissue
           5.2.2 Restraints
                    5.2.2.1 High Installation Costs of Breast Imaging Systems
                    5.2.2.2 Side Effects of Radiation Exposure
                    5.2.2.3 Errors in Breast Cancer Screening and Diagnosis
                    5.2.2.4 Stringent Regulatory Approval Procedures
                    5.2.2.5 Unfavorable Reimbursement Scenario in Developing Countries
           5.2.3 Opportunities
                    5.2.3.1 Emerging Economies Offer High Growth Potential
                    5.2.3.2 Technological Innovations in Breast Cancer Detection

6 Breast Imaging Market, By Type (Page No. - 45)
    6.1 Introduction
    6.2 Ionizing Technologies
           6.2.1 Full-Field Digital Mammography (FFDM)
           6.2.2 Analog Mammography
           6.2.3 3D Breast Tomosynthesis
           6.2.4 Positron Emission Tomography and Computed Tomography (PET-CT)
           6.2.5 Molecular Breast-Specific Gamma Imaging (MBI/BSGI)
           6.2.6 Cone-Beam Computed Tomography (CBCT)
           6.2.7 Positron Emission Mammography (PEM)
           6.2.8 Electric Impedance Tomography
    6.3 Non-Ionizing Technologies
           6.3.1 Breast Ultrasound
           6.3.2 Breast MRI
           6.3.3 Automated Whole-Breast Ultrasound (AWBU)
           6.3.4 Breast Thermography
           6.3.5 Optical Imaging

7 Breast Imaging Market, By Region (Page No. - 78)
    7.1 Introduction
    7.2 North America
           7.2.1 U.S.
           7.2.2 Canada
    7.3 Europe
           7.3.1 Germany
           7.3.2 France
           7.3.3 U.K.
           7.3.4 Rest of Europe
    7.4 Asia-Pacific
           7.4.1 Japan
           7.4.2 China
           7.4.3 India
           7.4.4 Rest of APAC
    7.5 Rest of the World (RoW)

8 Competitive Landscape (Page No. - 113)
    8.1 Overview
    8.2 Strategic Overview
    8.3 Market Share Analysis
    8.4 Competitive Situation and Trends
           8.4.1 Product Launches, Upgrades, and Approvals
           8.4.2 Partnerships, Agreements, and Collaborations
           8.4.3 Other Developments

9 Company Profile (Page No. - 119)
    9.1 Introduction
    9.2 Hologic, Inc.
           9.2.1 Business Overview
           9.2.2 Products Offered
           9.2.3 Recent Developments
           9.2.4 MnM View
    9.3 GE Healthcare (A Part of General Electric Company)
           9.3.1 Business Overview
           9.3.2 Products Offered
           9.3.3 Recent Developments
           9.3.4 MnM View
    9.4 Siemens Healthcare (A Part of Siemens AG)
           9.4.1 Business Overview
           9.4.2 Products Offered
           9.4.3 Recent Developments
           9.4.4 MnM View
    9.5 Philips Healthcare (A Part of Koninklijke Philips N.V.)
           9.5.1 Business Overview
           9.5.2 Products Offered
           9.5.3 Recent Developments
           9.5.4 MnM View
    9.6 Fujifilm Holdings Corporation
           9.6.1 Business Overview
           9.6.2 Products Offered
           9.6.3 Recent Developments
           9.6.4 MnM View
    9.7 Gamma Medica, Inc.
           9.7.1 Business Overview
           9.7.2 Products Offered
           9.7.3 Recent Developments
    9.8 Toshiba Corporation
           9.8.1 Business Overview
           9.8.2 Products Offered
           9.8.3 Recent Developments
    9.9 Sonocinι, Inc.
           9.9.1 Business Overview
           9.9.2 Products Offered
           9.9.3 Recent Developments
    9.10 Aurora Imaging Technology, Inc.
           9.10.1 Business Overview
           9.10.2 Products Offered
    9.11 Dilon Technologies, Inc.
           9.11.1 Business Overview
           9.11.2 Products Offered
           9.11.3 Recent Developments

10 Appendix (Page No. - 142)
     10.1 Discussion Guide*
     10.2 Additional Developments
              10.2.1 Hologic, Inc.
              10.2.2 GE Healthcare (A Part of General Electric Company)
              10.2.3 Philips Healthcare (A Part of Koninklijke Philips N.V.)
              10.2.4 Siemens Healthcare (A Part of Siemens AG)
              10.2.5 Gamma Medica, Inc
     10.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     10.4 Introducing RT: Real-Time Market Intelligence
     10.5 Available Customizations
     10.6 Related Reports


List of Tables (107 Tables)

Table 1 Growing Prevalence of Breast Cancer to Trigger Market Growth
Table 2 High Installation Costs of Breast Imaging Systems to Restrain Market Growth
Table 3 Emerging Markets Offer Significant Opportunities for Market Players
Table 4 Breast Imaging Market Size, By Type, 2014–2021 (USD Million)
Table 5 Ionizing Technologies Market Size, By Type,  2014–2021 (USD Million)
Table 6 Global Full-Field Digital Mammography Market Size, By Region,  2014–2021 (USD Million)
Table 7 North America: Full-Field Digital Mammography Market Size, By Country, 2014–2021 (USD Million)
Table 8 Europe: Full-Field Digital Mammography Market Size, By Country,  2014–2021 (USD Million)
Table 9 Asia-Pacific: Full-Field Digital Mammography Market Size, By Country,  2014–2021 (USD Million)
Table 10 Global Analog Mammography Market Size, By Region,  2014–2021 (USD Million)
Table 11 North America: Analog Mammography Market Size, By Country,  2014–2021 (USD Million)
Table 12 Europe: Analog Mammography Market Size, By Country, 2014–2021 (USD Million)
Table 13 Asia-Pacific: Analog Mammography Market Size, By Country,  2014–2021 (USD Million)
Table 14 Global 3D Breast Tomosynthesis Market Size, By Region,  2014–2021 (USD Million)
Table 15 North America: 3D Breast Tomosynthesis Market Size, By Country,  2014–2021 (USD Million)
Table 16 Europe: 3D Breast Tomosynthesis Market Size, By Country,  2014–2021 (USD Million)
Table 17 Asia-Pacific: 3D Breast Tomosynthesis Market Size, By Country, 2014–2021 (USD Million)
Table 18 Global Positron Emission Tomography and Computed Tomography Market Size, By Region, 2014–2021 (USD Million)
Table 19 North America: Positron Emission Tomography and Computed Tomography Market Size, By Country, 2014–2021 (USD Million)
Table 20 Europe: Positron Emission Tomography and Computed Tomography Market Size, By Country, 2014–2021 (USD Million)
Table 21 Asia-Pacific: Positron Emission Tomography and Computed Tomography Market Size, By Country, 2014–2021 (USD Million)
Table 22 Global Molecular Breast-Specific Gamma Imaging Market Size, By Region, 2014–2021 (USD Million)
Table 23 North America: Molecular Breast-Specific Gamma Imaging Market Size, By Country, 2014–2021 (USD Million)
Table 24 Europe: Molecular Breast-Specific Gamma Imaging Market Size, By Country, 2014–2021 (USD Million)
Table 25 Asia-Pacific: Molecular Breast-Specific Gamma Imaging Market Size, By Country, 2014–2021 (USD Million)
Table 26 Global Cone-Beam Computed Tomography Market Size, By Region,  2014–2021 (USD Million)
Table 27 North America: Cone-Beam Computed Tomography Market Size, By Country, 2014–2021 (USD Million)
Table 28 Europe: Cone-Beam Computed Tomography Market Size, By Country,  2014–2021 (USD Million)
Table 29 Asia-Pacific: Cone-Beam Computed Tomography Market Size, By Country, 2014–2021 (USD Million)
Table 30 Global Positron Emission Mammography Market Size, By Region,  2014–2021 (USD Million)
Table 31 North America: Positron Emission Mammography Market Size, By Country, 2014–2021 (USD Million)
Table 32 Europe: Positron Emission Mammography Market Size, By Country,  2014–2021 (USD Million)
Table 33 Asia-Pacific: Positron Emission Mammography Market Size, By Country,  2014–2021 (USD Million)
Table 34 Global Electric Impedance Tomography Market Size, By Region,  2014–2021 (USD Million)
Table 35 North America: Electric Impedance Tomography Market Size, By Country, 2014–2021 (USD Million)
Table 36 Europe: Electric Impedance Tomography Market Size, By Country,  2014–2021 (USD Million)
Table 37 Asia-Pacific: Electric Impedance Tomography Market Size, By Country,  2014–2021 (USD Million)
Table 38 Non-Ionizing Breast Imaging Market Size, By Type,2014–2021 (USD Million)
Table 39 Global Breast Ultrasound Market Size, By Region,2014–2021 (USD Million)
Table 40 North America: Breast Ultrasound Market Size, By Country,  2014–2021 (USD Million)
Table 41 Europe: Breast Ultrasound Market Size, By Country,2014–2021 (USD Million)
Table 42 Asia-Pacific: Breast Ultrasound Market Size, By Country,  2014–2021 (USD Million)
Table 43 Global Breast MRI Market Size, By Region, 2014–2021 (USD Million)
Table 44 North America: Breast MRI Market Size, By Country,2014–2021 (USD Million)
Table 45 Europe: Breast MRI Market Size, By Country, 2014–2021 (USD Million)
Table 46 Asia-Pacific: Breast MRI Market Size, By Country,2014–2021 (USD Million)
Table 47 Global Automated Whole-Breast Ultrasound Market Size, By Region,  2014–2021 (USD Million)
Table 48 North America: Automated Whole-Breast Ultrasound Market Size,  By Country, 2014–2021 (USD Million)
Table 49 Europe: Automated Whole-Breast Ultrasound Market Size, By Country,  2014–2021 (USD Million)
Table 50 Asia-Pacific: Automated Whole-Breast Ultrasound Market Size, By Country, 2014–2021 (USD Million)
Table 51 Global Breast Thermography Market Size, By Region,2014–2021 (USD Million)
Table 52 North America: Breast Thermography Market Size, By Country,  2014–2021 (USD Million)
Table 53 Europe: Breast Thermography Market Size, By Country,  2014–2021 (USD Million)
Table 54 Asia-Pacific: Breast Thermography Market Size, By Country,2014–2021 (USD Million)
Table 55 Global Optical Imaging Market Size, By Region, 2014–2021 (USD Million)
Table 56 North America: Optical Imaging Market Size, By Country, 2014–2021 (USD Million)
Table 57 Europe: Optical Imaging Market Size, By Country,2014–2021 (USD Million)
Table 58 Asia-Pacific: Optical Imaging Market Size, By Country,  2014–2021 (USD Million)
Table 59 Breast Imaging Market Size, By Region, 2014–2021 (USD Million)
Table 60 North America: Breast Imaging Market Size, By Country,  2014–2021 (USD Million)
Table 61 North America: Breast Imaging Market Size, By Type,2014–2021 (USD Million)
Table 62 North America: Ionizing Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 63 North America: Non-Ionizing Technologies Market Size,  By Type, 2014–2021 (USD Million)
Table 64 U.S.: Breast Imaging Market Size, By Type, 2014–2021 (USD Million)
Table 65 U.S.: Ionizing Technologies Market Size, By Type  2014–2021 (USD Million)
Table 66 U.S.: Non-Ionizing Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 67 Canada: Breast Imaging Market Size, By Type, 2014–2021 (USD Million)
Table 68 Canada: Ionizing Technologies Market Size, By Type,  2014–2021 (USD Million)
Table 69 Canada: Non-Ionizing Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 70 Europe: Breast Imaging Market Size, By Country,2014–2021 (USD Million)
Table 71 Europe: Breast Imaging Market Size, By Type, 2014–2021 (USD Million)
Table 72 Europe: Ionizing Technologies Market Size, By Type,  2014–2021 (USD Million)
Table 73 Europe: Non-Ionizing Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 74 Germany: Breast Imaging Market Size, By Type, 2014–2021 (USD Million)
Table 75 Germany: Ionizing Technologies Market Size, By Type,  2014–2021 (USD Million)
Table 76 Germany: Non-Ionizing Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 77 France: Breast Imaging Market Size, By Type, 2014–2021 (USD Million)
Table 78 France: Ionizing Technologies Market Size, By Type,  2014–2021 (USD Million)
Table 79 France: Non-Ionizing Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 80 U.K.: Breast Imaging Market Size, By Type, 2014–2021 (USD Million)
Table 81 U.K.: Ionizing Technologies Market Size, By Type,  2014–2021 (USD Million)
Table 82 U.K.: Non-Ionizing Technologies Market Size, By Type,  2014–2021 (USD Million)
Table 83 Rest of Europe: Breast Imaging Market Size, By Type,  2014–2021 (USD Million)
Table 84 Rest of Europe: Ionizing Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 85 Rest of Europe: Non-Ionizing Technologies Market Size,  By Type, 2014–2021 (USD Million)
Table 86 Asia-Pacific: Breast Imaging Market Size, By Country,  2014-2021 (USD Million)
Table 87 Asia-Pacific: Breast Imaging Market Size, By Type,2014-2021 (USD Million)
Table 88 Asia-Pacific: Ionizing Technologies Market Size, By Type, 2014-2021 (USD Million)
Table 89 Asia-Pacific: Non-Ionizing Technologies Market Size,  By Type, 2014-2021 (USD Million)
Table 90 Japan: Breast Imaging Market Size, By Type, 2014-2021 (USD Million)
Table 91 Japan: Ionizing Technologies Market Size, By Type,  2014-2021 (USD Million)
Table 92 Japan: Non-Ionizing Technologies Market Size, By Type, 2014-2021 (USD Million)
Table 93 China: Breast Imaging Market Size, By Type, 2014-2021 (USD Million)
Table 94 China: Ionizing Technologies Market Size, By Type,  2016-2021 (USD Million)
Table 95 China: Non-Ionizing Technologies Market Size, By Type, 2014-2021 (USD Million)
Table 96 India: Breast Imaging Market Size, By Type, 2014-2021 (USD Million)
Table 97 India: Ionizing Breast Imaging Technologies Market Size, By Type, 2014-2021 (USD Million)
Table 98 India: Non-Ionizing Breast Imaging Technologies Market Size, By Type, 2014-2021 (USD Million)
Table 99 RoAPAC : Breast Imaging Market Size, By Type, 2014-2021 (USD Million)
Table 100 RoAPAC : Ionizing Breast Imaging Technologies Market Size, By Type,  2014-2021 (USD Million)
Table 101 RoAPAC : Non-Ionizing Breast Imaging Technologies Market Size, By Type, 2014-2021 (USD Million)
Table 102 RoW: Breast Imaging Market Size, By Type, 2014-2021 (USD Million)
Table 103 RoW: Ionizing Breast Imaging Technologies Market Size, By Type,  2014-2021 (USD Million)
Table 104 RoW: Non-Ionizing Breast Imaging Technologies Market Size, By Type,  2014-2021 (USD Million)
Table 105 Top 5 Product Launches, Upgrades, and Approvals, 2013–2016
Table 106 Top 5 Partnerships, Agreements, and Collaborations, 2013–2016
Table 107 Top 5 Other Developments, 2013–2016
 
 
List of Figures (39 Figures)
 
Figure 1 Research Design
Figure 2 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 3 Breakdown of Demand-Side Primary Interviews: By End User and Region
Figure 4 Breast Imaging Market: Bottom-Up Approach
Figure 5 Breast Imaging Market: Top-Down Approach
Figure 6 Breast Imaging Market: Data Triangulation
Figure 7 Global Breast Imaging Market Size, By Type,  2016 vs. 2021 (USD Million)
Figure 8 Global Ionizing Breast Imaging Technologies Market Size, By Type, 2016 vs. 2021 (USD Million)
Figure 9 Global Non-Ionizing Breast Imaging Technologies Market Size,  By Type, 2016 vs. 2021 (USD Million)
Figure 10 Global Breast Imaging Market, By Region, 2016
Figure 11 Emerging Countries Offer High-Growth Opportunities for Players in the Breast Imaging Market
Figure 12 Ionizing Breast Imaging Technologies Will Continue to Dominate the Global Breast Imaging Market in 2021
Figure 13 Asia-Pacific 3D Breast Tomosynthesis Market to Witness the Highest Growth Rate During the Forecast Period
Figure 14 Breast Ultrasound Segment Dominates the Non-Ionizing Breast Imaging Market in All Regions
Figure 15 Breast Imaging Market Segmentation
Figure 16 Breast Imaging Market: Drivers, Restraints, and Opportunities
Figure 17 Breast Imaging Market, By Type, 2016 vs. 2021
Figure 18 FFDM to Command the Largest Share of the Ionizing Breast Imaging Technologies Market in 2016
Figure 19 North America to Hold the Major Share of the FFDM Market in 2016
Figure 20 Asia-Pacific to Be the Fastest-Growing Region in the 3D Breast Tomosynthesis Market
Figure 21 AWBU: the Fastest-Growing Segment During the Forecast Period
Figure 22 Europe is Expected to Hold the Second-Largest Share of the Breast Ultrasound Market in 2016
Figure 23 Europe to Hold Second-Largest Share of the Automated Whole-Breast Ultrasound Market in 2016
Figure 24 Ionizing and Non-Ionizing Breast Imaging Technologies Market Share, By Country, 2016
Figure 25 North America: Breast Imaging Market Snapshot 2016 and 2021
Figure 26 U.S. Breast Density Notification Law, By State, 2015
Figure 27 Europe: Breast Imaging Market Snapshot 2016 and 2021
Figure 28 Asia-Pacific: Breast Imaging Market Snapshot, 2016 and 2021
Figure 29 RoW: Breast Imaging Market Snapshot, 2016 and 2021
Figure 30 Leading Market Players Adopted Product Launches, Upgrades, and Approvals as Their Kew Growth Strategy From 2013 to 2016
Figure 31 Global Breast Imaging Market Share, By Key Player, 2015
Figure 32 Battle for Market Share : Product Launches, Upgrades, and Approvals–Key Growth Strategy Adopted By Players Between2013 & 2016
Figure 33 Geographic Revenue Mix of the Leading Market Players
Figure 34 Hologic, Inc.: Company Snapshot
Figure 35 General Electric Company: Company Snapshot
Figure 36 Siemens AG: Company Snapshot
Figure 37 Koninklijke Philips N.V.: Company Snapshot
Figure 38 Fujifilm Holdings Corporation: Company Snapshot
Figure 39 Toshiba Corporation: Company Snapshot

On the basis of type, the global breast imaging market is segmented into two major categories, namely, ionizing technologies and non-ionizing technologies. Ionizing technologies are further segmented into eight subsegments, namely, analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast-specific gamma imaging (MBI/BSGI), cone-beam computed tomography (CBCT), positron emission mammography (PEM), and electric impedance tomography. The 3D breast tomosynthesis segment is expected to grow at the highest CAGR in the next five years, owing to the increasing regulatory approvals for 3D breast tomosythesis systems, benefits offered by these systems over other technologies, and higher patient accessibility offered by these systems.

The non-ionizing breast imaging technologies segment is classified into five subsegments, namely, breast MRI, breast ultrasound, automated whole breast ultrasound (AWBU), breast thermography, and optical imaging. The automated whole-breast ultrasound (AWBU) segment is expected to grow at the highest CAGR in the next five years, owing to benefits such as high reproducibility, high resolution power with 3D capability, lower false positives, and faster imaging.

This report studies the breast imaging market over the forecast period of 2016 to 2021. The market is expected to reach USD 4.14 Billion by 2021, at a CAGR of 8.5% from 2016 to 2021. A number of factors such as rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues are driving the growth of the global breast imaging market. However, high installation cost of breast imaging systems, side effects of radiation exposure, and errors in breast cancer screening and diagnosis are some of the major factors restraining the growth of this market. In addition, stringent regulatory approval procedures and unfavorable reimbursement scenario in developing countries are expected to further restrain the growth of this market in the coming years.

The breast imaging market is segmented into four major regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is estimated to dominate the global breast imaging market, majorly due to the rising incidence of breast cancer, favorable reimbursement scenario, ongoing technological advancements by market players, implementation of new breast density notification law in the U.S., rapid growth in geriatric population, and growing demand for the use of low levels or negligible radiation doses in the region. On the other hand, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. The high growth in this market can majorly be attributed to the rising patient population, increasing healthcare expenditure, higher government spending on breast cancer research studies, and implementation of several programs focused on creating awareness about the early detection of breast cancer.

Product launches, upgrades, and approvals form the key growth strategies adopted by major players operating in the global breast imaging market. Moreover, a large number of players are focusing on growth strategies such as partnerships, agreements, and collaborations to strengthen their product portfolios and expand their geographic presence in the global breast imaging market.

Hologic, Inc. (U.S.), GE Healthcare (U.K.), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), Fujifilm Holdings Corporation (Japan), Gamma Medica, Inc. (U.S.), Toshiba Corporation (Japan), Sonocine, Inc. (U.S.), Aurora Imaging Technology, Inc. (U.S.), and Dilon Technologies, Inc. (U.S.) are some of the key players operating in the global breast imaging market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports